C12Y 207/03002
Creatine kinase
Official title: Creatine kinase (2.7.3.2)
C12Y207/03002 (Creatine kinase) appears on 11 US grants and 14 published applications in this corpus.
Search patents in C12Y- Granted patents
- 11
- Published applications
- 14
- Assignees
- 15
- Inventors
- 53
- Latest grant
- 2 May 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 2 |
| 2016 | 1 | 1 |
| 2017 | 0 | 1 |
| 2018 | 2 | 1 |
| 2019 | 2 | 0 |
| 2020 | 1 | 2 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 2 |
| 2024 | 0 | 3 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Portable fluidic platform for rapid cell-free production of protein biologics2 May 2023US 11,639,514 B2Leidos, Inc.
- Portable fluidic platform for rapid cell-free production of protein biologics26 May 2020US 10,662,457 B1Leidos, Inc.
- Measuring method and composition using kinase12 Nov 2019US 10,472,665 B2Asahi Kasei Pharma Corporation
- Use of creatine kinase and derived peptides thereof to relieve pain22 Oct 2019US 10,449,235 B2Centre National De La Recherche Scientifique
- Preservation and reconstitution of cell-free protein expression systems10 Apr 2018US 9,937,239 B2The Johns Hopkins University
- Point-of-Care Device for the Determination of Creatine Phosphokinase (CPK) in Biological Samples16 Oct 2025US 2025/0320540 A1In Vitro Diagnostic Solutions
- Method for Producing Circular DNA24 Oct 2024US 2024/0352495 A1Moderna Enzymatics Co., Ltd.
- Enzymatic synthesis of ntp and nqp27 Jun 2024US 2024/0209406 A1Codexis, Inc.
- Engineered 3-o-kinase variants and methods of use27 Jun 2024US 2024/0209408 A1Codexis, Inc.
- Muscle-specific hybrid promoter2 Nov 2023US 2023/0346976 A1Aldevron, LLC
Most cited
By later US patents
- Inactivation of enzymes57US 4,483,922 AAMF Incorporated · 1984
- Method of inhibiting transformation of cells in which purine metabolic enzyme activity is elevated39US 5,324,731 AAmira, Inc. · 1994
- Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent24US 5,676,978 AAmira, Inc. · 1997
- Creatine analogs having antiviral activity22US 5,321,030 AAmira, Inc. · 1994
- Portable fluidic platform for rapid cell-free production of protein biologics3US 9,908,064 B2Leidos, Inc. · 2018